|
Accelerate Diagnostics Inc (NASDAQ: AXDX) |
|
Accelerate Diagnostics Inc
AXDX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Accelerate Diagnostics Inc 's sales fell
by -19.09 % in IV. Quarter 2024 from the same quarter a year ago.
Laboratory Analytical Instruments industry recorded
growth of revenues by 1.41 %
Accelerate Diagnostics Inc net loss decreased from $-13 millions, to $-10 millions in IV. Quarter 2024,
• More on AXDX's Growth
|
|
Accelerate Diagnostics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.2 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.53 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.16.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.93.
• More on AXDX's Valuation
|
|
|
|
|
Accelerate Diagnostics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.2 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.53 |
PE TTM
|
|
Company's Price to Sales ratio is at 1.16.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.93.
• More on AXDX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com